# Boston Scientific Corporation (BSX) — Q4-2012 Earnings Results

**Report date:** 2013-01-29 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q4-2012

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Up 3.5%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.18 | N/A | +65.14% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on the company's performance. They emphasized their commitment to innovation and market expansion.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They expressed confidence in future growth despite not providing specific guidance.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's strong EPS performance, exceeding expectations significantly, led to a 3.5% increase in stock price. Investors reacted positively to the company's ability to outperform on earnings, even without revenue figures or specific guidance. The management's optimistic tone suggests confidence in future growth, which may further bolster investor sentiment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q4-2012_